From mechanism to application: programmed cell death pathways in nanomedicine-driven cancer therapies
Programmed cell death (PCD) plays a crucial role in preventing cancer initiation and progression. Among the diverse PCD pathways, cuproptosis, pyroptosis, and ferroptosis have garnered attention for their unique mechanisms, which not only directly eliminate tumor cells but also enhance anti-tumor im...
Saved in:
| Main Authors: | Zhan Zhang, Yuanzhen Wu, Yanchen Liu, Jingyu Zhang, Yan Zhang, Yunlu Dai, Caigang Liu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
KeAi Communications Co., Ltd.
2025-10-01
|
| Series: | Bioactive Materials |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2452199X25002889 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Nanomedicine initiates ferroptosis for enhanced lung cancer therapy
by: Yitianhe Xu, et al.
Published: (2025-12-01) -
Which one of the types of programmed cell death is reduced by aerobic exercise?
by: Peyman Akraminia, et al.
Published: (2024-09-01) -
Engineered anti-cancer nanomedicine for synergistic cuproptosis-immunotherapy
by: Jiaxin Li, et al.
Published: (2025-10-01) -
Targeting programmed cell death pathways: emerging therapeutic strategies for diabetic kidney disease
by: Lin Wang, et al.
Published: (2025-06-01) -
Neuroinflammation in Age-Related Neurodegenerative Diseases: Role of Mitochondrial Oxidative Stress
by: Xenia Abadin, et al.
Published: (2024-11-01)